PunjiPUNJI
Chemicals & PetrochemicalsSmall Cap

KRONOX LAB SCIENCES LIMITED

KRONOX · ISIN: INE0ATZ01017

KRONOX LAB SCIENCES LIMITED is a small cap company in the Chemicals & Petrochemicals sector, listed on the NSE under ISIN INE0ATZ01017.

Price and day-range figures above come from the latest NSE/BSE close, not a delayed quote. Where shown, RSI (14-day), SMA50/SMA200, and ADX measure momentum and trend from real daily closing prices - an RSI above 70 or below 30 typically signals overbought or oversold conditions, and a price above its SMA200 is a common long-term uptrend marker. ADTV (20-day average daily traded value) reflects real liquidity, not a projection. Fundamentals, when available, come from the company's own filed financials rather than a third-party estimate.

Close (as of 2026-10-29)
₹194.73
-0.67% today
Day Range
₹191.2 - ₹198.45
Market Cap (Small Cap)
₹738.403 Cr
Quality Score (as of 2026-03-31)
50/100

Price History

CHART

KRONOX LAB SCIENCES LIMITED - growth of ₹100

Growth of ₹100 invested on 2025-10-31, not raw price - the standard way to compare performance regardless of price level. Daily resolution for the last 90 days, weekly up to 2 years, monthly beyond that.

-1530741181622025-10-312026-02-012026-05-082026-08-032026-08-202026-09-082026-09-282026-10-162026-10-29

1M

-10.01%

3M

+28.7%

6M

+38.48%

1Y

+29.38%

3Y CAGR

-

5Y CAGR

-

Earnings (TTM)

LEARN: Revenue and PAT · EPS · P/E

CHART

KRONOX LAB SCIENCES LIMITED - revenue & profit (TTM)

Trailing-twelve-month figures by reported quarter, in ₹ Cr. Latest quarter: 2026-06-30.

0 Cr29 Cr59 Cr88 Cr118 CrQ3 FY2026Q4 FY2026Q1 FY2027
Revenue (TTM)PAT (TTM)

Technicals

Not available for this stock yet.

Shareholding Pattern

Not available for this stock yet.

Corporate Actions

No corporate actions on record for this stock.

Recent Deals

DateTypeQuantity
2026-08-21BULK2,87,808
2026-08-21BULK7,72,632
2026-08-21BULK6,27,218
2026-08-21BULK2,37,220
2026-08-21BULK4,04,367
2026-08-21BULK2,28,658
2026-08-21BULK4,18,317
2026-08-21BULK2,28,658
2026-08-21BULK2,69,340
2026-08-21BULK2,69,340
2026-08-21BULK2,37,220
2026-08-21BULK4,04,367
2026-08-21BULK4,18,317
2026-08-21BULK6,22,248
2026-08-21BULK2,30,158
2026-08-21BULK2,50,245
2026-08-21BULK2,50,245
2026-08-21BULK2,30,158
2026-08-21BULK10,10,563
2026-08-21BULK2,87,649

Frequently asked questions

What is KRONOX LAB SCIENCES LIMITED's 1-year and 3-year return?

KRONOX LAB SCIENCES LIMITED's 1-year price return is +29.38%. Both are price-only returns (no dividends added back), computed from the nearest available trading day to each anniversary - not a forecast of future performance.

What is KRONOX LAB SCIENCES LIMITED's latest financial performance?

KRONOX LAB SCIENCES LIMITED's trailing-twelve-month (TTM) revenue as of 2026-06-30 is ₹105 Cr, with a TTM profit after tax of ₹29 Cr and an EBITDA margin of null%. TTM figures sum the most recent four reported quarters rather than a single quarter, which smooths out seasonal swings in a business's revenue and profit. EPS (earnings per share) over this TTM window is ₹7.79.

What is KRONOX LAB SCIENCES LIMITED's quality score?

KRONOX LAB SCIENCES LIMITED has a Punji quality score of 50 out of 100 as of 2026-03-31. This composite score is computed from the company's reported fundamentals (profitability, balance-sheet strength, and consistency of earnings, among other factors) and is designed to be comparable across companies in different sectors. A higher score indicates a fundamentally stronger business by these measures, though it isn't a price target or a buy/sell signal - a high-quality company can still be expensively priced, and a lower-scoring one can still be a reasonable investment at the right valuation.

Has KRONOX LAB SCIENCES LIMITED seen any recent bulk or block deals?

Yes, as of 2026-08-21 - the most recent recorded deal was a BULK on 2026-08-21 for 2,87,808 shares. Bulk and block deals are large trades (above exchange-defined thresholds) that must be publicly disclosed, and are often watched as a signal of institutional or high-net-worth investor conviction - though a single deal doesn't establish a trend, and the counterparty's reasons for buying or selling aren't disclosed alongside the trade itself.

Stock data · Not financial advice · Past performance does not indicate future returns